SCHEMBL6437896

SCHEMBL6437896

N#Cc1nccc(Br)c1Br

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 1/20 0.32
PRKCI P41743 1/20 0.32
HTT P42858 1/20 0.31
ALDH1A1 P00352 2/20 0.31
CYP11B1 P15538 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
MAPK1 P28482 1/20 0.31
RAB9A P51151 1/20 0.31
CACNA1B Q00975 1/20 0.31
APBA1 Q02410 1/20 0.31
PAX8 Q06710 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31
DAO P14920 1/20 0.31
PLCG1 P19174 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14842294 0.78 TDO2 (0.33) ERBB2PRKCICYP11B1
SCHEMBL30527748 0.78 MEN1 (0.39) ERBB2PRKCIHTTALDH1A1MAPT
SCHEMBL1841305 0.78 CCR1 (0.35) ERBB2ALDH1A1LMNAMAPTRAB9A
SCHEMBL3360364 0.78 KDM4E (0.36) ERBB2PRKCIALDH1A1KDM4EPOLB
SCHEMBL17416894 0.78 MEN1 (0.39) ERBB2PRKCIHTTALDH1A1MAPT
SCHEMBL25299754 0.78 NTRK1 (0.33) ERBB2PRKCIALDH1A1LMNAMAPT
SCHEMBL14783084 0.78 KDM4E (0.40) ERBB2PRKCIALDH1A1KDM4EPOLB
SCHEMBL25257654 0.74 TDO2 (0.31)
SCHEMBL30527595 0.74 PLCG1 (0.36) HTTALDH1A1MAPTMAPK1RAB9A
SCHEMBL30510443 0.74 TDO2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501825-A2 SUBSTITUTED IMIDAZOLYLMETHYL PYRIDINE AND PYRAZINE DERIVATIVES: GABA A RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 2005-02-02 EP disclosed
WO-2004041809-A2 SUBSTITUTED IMIDAZOLYLMETHYL PYRIDINE AND PYRAZINE DERIVATIVES AND THEIR USE AS GABAA RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 2004-05-21 WO disclosed